Auenheim, France

Marie-Madeleine Bohn

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: R.p.scherer Technologies, Inc.. Active years: 2005-2010.


% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marie-Madeleine Bohn: Innovator in Pharmaceutical Composition

Introduction

Marie-Madeleine Bohn is a notable inventor based in Auenheim, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions for soft capsules. With a total of 2 patents, her work focuses on innovative methods for treating cancer.

Latest Patents

One of her latest patents is an oral pharmaceutical composition for soft capsules containing vinorelbine. This invention relates to a pharmaceutical composition that is suitable for encapsulation in soft capsules. The composition includes vinorelbine or a pharmaceutically acceptable salt thereof, along with ethanol, water, glycerol, and polyethylene glycol. In a preferred embodiment, the tartrate salt form of vinorelbine is utilized. The invention also outlines a method for treating cancer by orally administering a soft capsule containing this pharmaceutical composition.

Career Highlights

Marie-Madeleine Bohn is associated with R.P. Scherer Technologies, Inc., where she applies her expertise in pharmaceutical innovations. Her work has been instrumental in advancing the field of cancer treatment through improved drug delivery systems.

Collaborations

Marie-Madeleine collaborates with Elie Leverd, contributing to the development of innovative pharmaceutical solutions.

Conclusion

Marie-Madeleine Bohn's contributions to the pharmaceutical industry, particularly in the area of cancer treatment, highlight her role as a leading inventor. Her innovative approaches continue to pave the way for advancements in drug formulation and delivery.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…